Profile data is unavailable for this security.
About the company
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
- Revenue in JPY (TTM)34.72bn
- Net income in JPY7.66bn
- Incorporated1975
- Employees732.00
- LocationJCR Pharmaceuticals Co Ltd3-19, Kasuga-choASHIYA-SHI 659-0021JapanJPN
- Phone+81 797328591
- Websitehttp://www.jcrpharm.co.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | 75.36bn | 12.95bn | 220.05bn | 1.22k | 14.22 | 1.34 | 14.37 | 2.92 | 336.77 | 336.77 | 1,960.63 | 3,561.82 | 0.4685 | 2.24 | 3.73 | 62,026,340.00 | 8.05 | 12.22 | 9.27 | 14.84 | 54.13 | 56.33 | 17.18 | 19.99 | 4.44 | -- | 0.0276 | 32.46 | -15.97 | -7.33 | -30.80 | -8.71 | -6.60 | 1.98 |
| Sawai Group Holdings Co Ltd | 193.76bn | 13.18bn | 224.65bn | 3.00k | 17.07 | 1.01 | 7.56 | 1.16 | 300.53 | 300.53 | 4,421.52 | 5,059.43 | 0.4994 | 1.53 | 3.17 | 64,523,140.00 | 3.02 | 5.02 | 4.15 | 6.78 | 37.94 | 40.03 | 6.04 | 9.65 | 1.45 | 49.85 | 0.2259 | 32.93 | 2.56 | 8.68 | -35.99 | -6.38 | 3.51 | 1.61 |
| Tsumura & Co | 130.89bn | 16.68bn | 287.08bn | 3.83k | 17.16 | 1.28 | 11.46 | 2.19 | 217.97 | 217.97 | 1,710.76 | 2,922.86 | 0.4093 | 0.7252 | 2.66 | 34,173,890.00 | 5.04 | 5.13 | 6.25 | 6.19 | 55.78 | 58.02 | 12.32 | 11.69 | 2.53 | -- | 0.1806 | 33.60 | 6.19 | 3.05 | 11.38 | 4.07 | 4.01 | 0.00 |
| Hisamitsu Pharmaceutical Co Inc | 117.39bn | 11.50bn | 361.95bn | 2.77k | 30.23 | 1.36 | 22.80 | 3.08 | 140.60 | 140.60 | 1,435.28 | 3,118.64 | 0.3933 | 2.57 | 3.39 | 42,378,700.00 | 3.95 | 5.94 | 4.40 | 6.77 | 60.11 | 62.17 | 10.04 | 12.63 | 6.73 | -- | 0.0054 | 39.53 | -18.78 | -6.69 | -50.52 | -12.25 | -8.03 | 0.8601 |
| JCR Pharmaceuticals Co Ltd | 34.72bn | 7.66bn | 379.59bn | 732.00 | 47.46 | 9.30 | 39.45 | 10.93 | 61.67 | 61.67 | 279.63 | 314.85 | 0.5234 | 0.6713 | 3.98 | 47,427,600.00 | 11.54 | 8.29 | 18.57 | 10.68 | 75.79 | 69.85 | 22.05 | 15.61 | 1.16 | -- | 0.3164 | 26.88 | 21.40 | 11.52 | 157.36 | 30.96 | 39.71 | 18.13 |
| TAKARA BIO INC. | 54.42bn | 15.17bn | 386.53bn | 1.54k | 25.48 | 4.81 | 20.44 | 7.10 | 125.96 | 125.96 | 451.94 | 668.00 | 0.6282 | 1.55 | 5.53 | 35,360,620.00 | 17.56 | 5.77 | 20.25 | 6.37 | 74.07 | 61.33 | 27.96 | 11.66 | 2.71 | -- | 0.00 | 22.95 | 33.33 | 9.16 | 149.99 | 48.23 | 30.09 | 54.80 |
| Alfresa Holdings Corporation | 2.60tn | 22.03bn | 398.12bn | 12.05k | 16.28 | 0.7378 | 11.68 | 0.1533 | 104.09 | 104.09 | 12,267.73 | 2,296.01 | 1.92 | 16.15 | 4.29 | 215,586,900.00 | 1.63 | 2.64 | 4.23 | 7.25 | 6.78 | 7.33 | 0.8479 | 1.32 | 1.07 | -- | 0.0012 | 27.87 | -3.53 | 0.2069 | -39.16 | -6.87 | 5.04 | 9.94 |
| ROHTO PHARMACEUTICAL CO., LTD. | 184.96bn | 19.54bn | 410.95bn | 6.60k | 20.38 | 2.47 | 15.62 | 2.22 | 170.78 | 170.78 | 1,616.79 | 1,406.33 | 0.8428 | 2.38 | 4.61 | 28,041,390.00 | 8.92 | 6.13 | 12.00 | 8.75 | 58.86 | 59.47 | 10.58 | 6.96 | 1.82 | -- | 0.0587 | 22.70 | -3.74 | 1.65 | 8.65 | 12.97 | 16.85 | 6.96 |
| Peptidream Inc | 11.45bn | 4.33bn | 485.59bn | 128.00 | 112.15 | 21.89 | 98.76 | 42.41 | 33.30 | 33.30 | 88.90 | 170.59 | 0.5201 | 3.78 | 13.18 | 89,445,060.00 | 19.66 | -- | 21.52 | -- | 80.85 | -- | 37.81 | -- | 6.70 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Medipal Holdings Corp | 3.24tn | 26.47bn | 527.44bn | 12.97k | 18.25 | 0.8568 | 10.32 | 0.1627 | 118.18 | 118.18 | 14,532.31 | 2,517.51 | 1.93 | 20.26 | 4.57 | 249,929,700.00 | 2.18 | 2.63 | 5.96 | 7.42 | 6.63 | 7.13 | 1.13 | 1.33 | 1.07 | -- | 0.0449 | 25.33 | -1.29 | 1.18 | -36.98 | -4.91 | -16.41 | 8.45 |
Data as of Sep 24 2021. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY
7.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 Aug 2021 | 2.34m | 1.80% |
| The Vanguard Group, Inc.as of 03 Sep 2021 | 1.32m | 1.02% |
| Norges Bank Investment Managementas of 31 Dec 2020 | 920.40k | 0.71% |
| Nikko Asset Management Co., Ltd.as of 02 Sep 2021 | 866.60k | 0.67% |
| Daiwa Asset Management Co. Ltd.as of 31 Aug 2021 | 857.80k | 0.66% |
| Shiozumi Asset Management Co. Ltd.as of 31 Jul 2021 | 790.00k | 0.61% |
| BlackRock Fund Advisorsas of 02 Sep 2021 | 741.40k | 0.57% |
| Tokio Marine Asset Management Co., Ltd.as of 21 Jun 2021 | 714.60k | 0.55% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 02 Sep 2021 | 536.40k | 0.41% |
| Asset Management One Co., Ltd.as of 31 Aug 2021 | 490.09k | 0.38% |
More ▼
Data from 31 Dec 2020 - 31 Jul 2021Source: FactSet Research Systems Inc.
